All Stories

  1. Mavrilimumab: a unique insight and update on the current status in the treatment of rheumatoid arthritis

    Article • Expert Opinion on Investigational Drugs, June 2019, Taylor & Francis

    Andrea Becciolini, Ennio Giulio Favalli

  2. The Use of Rheumatic Disease Comorbidity Index for Predicting Clinical Response and Retention Rate in a Cohort of Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Alpha Inhibitors

    Article • BioMed Research International, January 2019, Hindawi Publishing Corporation

    Ennio Giulio Favalli

  3. Vitamin D and Spondyloarthritis: Review of the Literature

    Article • The Open Rheumatology Journal, December 2018, Bentham Science Publishers

    Ennio Giulio Favalli

  4. Tocilizumab in the treatment of rheumatoid arthritis: an evidence-based review and patient selection

    Article • Drug Design Development and Therapy, December 2018, Dove Medical Press

    Andrea Becciolini, Ennio Giulio Favalli

  5. The Management of Acute Anterior Uveitis Complicating Spondyloarthritis: Present and Future

    Article • BioMed Research International, October 2018, Hindawi Publishing Corporation

    Andrea Becciolini, Ennio Giulio Favalli

  6. Sarilumab: patient-reported outcomes in rheumatoid arthritis

    Article • Patient Related Outcome Measures, August 2018, Dove Medical Press

    Andrea Becciolini, Ennio Giulio Favalli

  7. The role of concomitant methotrexate dosage and maintenance over time in the therapy of rheumatoid arthritis patients treated with adalimumab or etanercept: retrospective analysis of a local registry

    Article • Drug Design Development and Therapy, May 2018, Dove Medical Press

    Andrea Becciolini, Ennio Giulio Favalli

  8. A review of the literature analyzing benefits and concerns of infliximab biosimilar CT-P13 for the treatment of rheumatologic diseases: focus on interchangeability

    Article • Drug Design Development and Therapy, June 2017, Dove Medical Press

    Andrea Becciolini, elena agape, Ennio Giulio Favalli

  9. Profile of sarilumab and its potential in the treatment of rheumatoid arthritis

    Article • Drug Design Development and Therapy, May 2017, Dove Medical Press

    Andrea Becciolini, Ennio Giulio Favalli

  10. Spotlight on mavrilimumab for the treatment of rheumatoid arthritis: evidence to date

    Article • Drug Design Development and Therapy, January 2017, Dove Medical Press

    Andrea Becciolini, Ennio Giulio Favalli

  11. Persistence, switch rates, drug consumption and costs of biological treatment of rheumatoid arthritis: an observational study in Italy

    Article • ClinicoEconomics and Outcomes Research, December 2016, Dove Medical Press

    Mr Roberto Ravasio, Ennio Giulio Favalli